title: Antithrombotic and thrombolytic therapy in acute cardiac care.
abstract: This article explores the use of antithrombotic and thrombolytic therapy in acute cardiac care, and looks at traditional anticoagulant agents, newer antithrombin agents, thrombolytic agents, and others.
authors.affiliation: Rush Heart Institute, Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois, USA.
authors.forename: R
authors.initials: R
authors.lastname: Sundrani
authors.forename: L W
authors.initials: LW
authors.lastname: Klein
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use*; D003327:Coronary Disease / Q000188:drug therapy* / Q000517:prevention & control; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006493:Heparin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D013917:Thrombin / Q000037:antagonists & inhibitors
chemical_list: D000925:Anticoagulants; D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight; D010975:Platelet Aggregation Inhibitors; C078918:ITF 300; D006493:Heparin; D013917:Thrombin